• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血友病 B 的围手术期管理:对证据和当前实践的批判性评估。

Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices.

机构信息

St. Jude Children's Research Hospital, Memphis, USA.

IRCCS Cà Granda Foundation, Maggiore Hospital, Milan, Italy.

出版信息

Haemophilia. 2017 Nov;23(6):821-831. doi: 10.1111/hae.13279. Epub 2017 Jul 27.

DOI:10.1111/hae.13279
PMID:28752639
Abstract

BACKGROUND

While there is substantial literature addressing the principles of general management of haemophilia, literature on perioperative management of haemostasis is scarce.

OBJECTIVE

The aim of this study was to better understand perioperative management among congenital haemophilia B patients (without inhibitors) and to gain insights into real-world surgical practices.

METHOD

A systematic literature review, with an emphasis on haemophilia B, was conducted using EMBASE , Medline and the Cochrane Library. Studies from 1974 to June 2015 were accessed, and 132 studies were eligible for the full-study review. An international expert panel with five haematologists and one surgeon reviewed the resulting literature and provided further insights.

RESULTS

The literature review revealed that documented experience in the perioperative management of bleeding risk in haemophilia B patients is relatively scarce. Therefore, the review was amended to provide a comprehensive overview of the perioperative management for haemophilia A and B patients; the expert panel applied a particular focus to haemophilia B. Several gaps were identified in the literature including the lack of consensus on defining surgery in terms of bleeding risk, optimal factor levels during surgery and lack of robust evidence on surgical outcomes. The ensuing discussions with the expert panel provided validation of some of the results from the systematic literature review and proposed future directions for perioperative management. Suggestions included collaboration with haemophilia treatment centres (HTCs) to collect real-world data on perioperative management, establishing the need for optimal factor level monitoring practice, and the appropriate adoption of extended half-life products in clinical settings.

摘要

背景

虽然有大量文献探讨了血友病的一般管理原则,但关于止血围手术期管理的文献却很少。

目的

本研究旨在更好地了解先天性乙型血友病(无抑制剂)患者的围手术期管理,并深入了解实际的手术实践。

方法

采用 EMBASE、Medline 和 Cochrane Library 进行了系统的文献回顾,重点关注乙型血友病。检索了 1974 年至 2015 年 6 月的文献,有 132 项研究符合全文审查标准。一个由五名血液学家和一名外科医生组成的国际专家小组对相关文献进行了回顾,并提供了进一步的见解。

结果

文献回顾表明,关于乙型血友病患者围手术期出血风险管理的记录经验相对较少。因此,该综述进行了修订,以全面概述血友病 A 和 B 患者的围手术期管理;专家组特别关注乙型血友病。文献中存在一些空白,包括在手术出血风险、手术期间最佳因子水平以及缺乏关于手术结果的有力证据等方面缺乏共识。随后与专家组的讨论验证了系统文献综述的一些结果,并提出了围手术期管理的未来方向。建议包括与血友病治疗中心(HTC)合作收集围手术期管理的真实数据,建立最佳因子水平监测实践的必要性,以及在临床环境中适当采用长半衰期产品。

相似文献

1
Perioperative management of haemophilia B: A critical appraisal of the evidence and current practices.血友病 B 的围手术期管理:对证据和当前实践的批判性评估。
Haemophilia. 2017 Nov;23(6):821-831. doi: 10.1111/hae.13279. Epub 2017 Jul 27.
2
Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.围手术期给予缓冲与非缓冲晶体静脉输液以改善成人外科手术后的结局。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD004089. doi: 10.1002/14651858.CD004089.pub3.
3
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
4
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.抗纤维蛋白溶解疗法用于预防接受小型口腔手术或拔牙的抗凝剂使用者的口腔出血。
Cochrane Database Syst Rev. 2018 Jul 2;7(7):CD012293. doi: 10.1002/14651858.CD012293.pub2.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Limited versus full sternotomy for aortic valve replacement.主动脉瓣置换术的有限胸骨切开术与全胸骨切开术对比
Cochrane Database Syst Rev. 2017 Apr 10;4(4):CD011793. doi: 10.1002/14651858.CD011793.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia.血友病疾病负担:血友病成本效益文献的系统评价。
J Manag Care Spec Pharm. 2018 Jul;24(7):632-642. doi: 10.18553/jmcp.2018.24.7.632.
9
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.用于预防既往接受过治疗的 A 型或 B 型血友病患者出血和出血相关并发症的凝血因子浓缩物。
Cochrane Database Syst Rev. 2021 Aug 18;8(8):CD014201. doi: 10.1002/14651858.CD014201.
10
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.

引用本文的文献

1
Management of Bleeding Diathesis in Elective and Orthopaedic Trauma: A Review.择期手术及骨科创伤中出血素质的管理:综述
J Am Acad Orthop Surg. 2025 Feb 15;33(4):168-177. doi: 10.5435/JAAOS-D-23-01109. Epub 2024 Oct 1.
2
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis.重组FIX Fc用于B型血友病的大手术:FIX血浆活性水平与有效止血
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102169. doi: 10.1016/j.rpth.2023.102169. eCollection 2023 Aug.
3
Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (rIX-FP): A case report.
使用阿布尔曲帕诺考因子(重组人凝血因子IX融合蛋白)治疗的乙型血友病患者心脏手术期间出色的止血控制:一例报告
Clin Case Rep. 2023 Jun 15;11(6):e7439. doi: 10.1002/ccr3.7439. eCollection 2023 Jun.
4
Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report.B型血友病患者进行心脏大手术时使用重组FIX Fc融合蛋白替代治疗:一例报告
Ther Adv Hematol. 2022 Jul 26;13:20406207221104595. doi: 10.1177/20406207221104595. eCollection 2022.
5
A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors.一种针对无抑制物的重度甲型血友病难治性患者的德尔菲共识方法。
J Blood Med. 2021 Oct 21;12:913-928. doi: 10.2147/JBM.S334852. eCollection 2021.
6
Vascularized Free Tissue Transfer in a Patient with Hemophilia B: Case Report and Literature Review.B型血友病患者的带血管蒂游离组织移植:病例报告及文献综述
Case Rep Surg. 2019 Dec 29;2019:5430786. doi: 10.1155/2019/5430786. eCollection 2019.
7
GlycoPEGylated recombinant factor IX for hemophilia B in context.用于B型血友病的糖基化聚乙二醇化重组因子IX相关情况
Drug Des Devel Ther. 2018 Sep 11;12:2933-2943. doi: 10.2147/DDDT.S121743. eCollection 2018.